MOR
MorphoSys AG ADR

524
Loading...
Loading...
News
all
press releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of...
PR Newswire·1y ago
News Placeholder
More News
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring...
PR Newswire·1y ago
News Placeholder
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares (ADSs) from the Nasdaq...
Business Wire·1y ago
News Placeholder
Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm
Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm PR Newswire NEW YORK, July 8, 2024 NEW YORK, July...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of...
PR Newswire·1y ago
News Placeholder
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of MorphoSys AG (NASDAQ: MOR) to Novartis for 68.00 per share in cash is fair to MorphoSys shareholders. Halper Sadeh...
Business Wire·1y ago
News Placeholder
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys Minority Shareholders
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the acquisition...
Business Wire·1y ago
News Placeholder
MorphoSys AG Reports First Quarter 2024 Financial Results
MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024. The proposed acquisition by Novartis is advancing steadily, and we continue to anticipate its closure in the first...
Business Wire·1y ago
News Placeholder
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly to acute myeloid leukemia. FDA alerted. Novartis acquisition proceeds...
Benzinga·1y ago
News Placeholder
Futures Rise, Yen Downgraded To Banana Republic Currency After Another Rollercoaster Session
Futures Rise, Yen Downgraded To Banana Republic Currency After Another Rollercoaster Session US equity futures swung between gains and losses and traded near session highs as US traders...
Zero Hedge·1y ago

Latest MOR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.